IRVING, TX - The End Drug Shortages Alliance (EDSA) announces the appointment of Terri Lyle Wilson, vice president of pharmacy for The Children’s Hospital Association, as its new chair. Wilson succeeds past-board chair Eric Tichy, PharmD, MBA, FCCP, division chair, pharmacy supply solutions, Mayo Clinic.

Tichy helped launch the End Drug Shortages Alliance in 2021 and was appointed chair in December 2021. Under his leadership, EDSA has grown to a non-profit organization of 80 member organizations with more than 255 active participants, including representatives from healthcare providers, pharmaceutical manufacturers, suppliers, distributors, group purchasing organizations and other thought leaders.

During Tichy’s tenure as board chair, EDSA responded to market supply disruptions with expert analysis and drug shortage mitigation strategies, including:

Wilson, who's been involved with EDSA since its beginning, brings a wealth of knowledge and experience to her new role. As the vice president of pharmacy for Children's Hospital Association, Wilson is a proven leader in the pharmacy industry, advocating for improved patient care and access to medication.

"I am very grateful to Eric for his leadership and am honored to step into the role of board chair for the End Drug Shortages Alliance," said Wilson. "I look forward to working with this dedicated group of individuals to continue our efforts in addressing and mitigating drug shortages for the betterment of patient care for children and adults."

Wilson will lead EDSA in its five-year strategy that will include developing drug shortage communication standards across the industry; executing a centralization strategy for communication of drug shortages to all industry stakeholders; and establishing and publishing guidance on inventory management best practices.

EDSA also welcomes its newly appointed chair-elect Jason Chou, vice president pharmacy services, Ochsner Health and Jessica Daley, group vice president, supply chain, Premier, Inc. as treasurer.

About End Drug Shortages Alliance

The End Drug Shortages Alliance is a collaboration of healthcare industry stakeholders, including providers, group purchasing organizations, manufacturers, distributors and other industry thought leaders dedicated to solving the pharmaceutical supply challenges that disrupt access to essential medications in the U.S. We prioritize initiatives focused on transparency, quality, redundancy and production of additional supply to achieve undisrupted access to essential medications for healthcare providers and patients.